William Hrushesky to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications William Hrushesky has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.757
-
Circadian timing in cancer treatment: the biological foundation for an integrative approach. Integr Cancer Ther. 2003 Jun; 2(2):105-11.
Score: 0.167
-
Reprogramming SynchroMed pumps: unanticipated inaccuracy. J Clin Oncol. 1991 Jun; 9(6):1089-90.
Score: 0.073
-
Control of a murine plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment. J Natl Cancer Inst. 1989 Jan 18; 81(2):135-45.
Score: 0.062
-
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer. Clin Colorectal Cancer. 2008 Mar; 7(2):134-9.
Score: 0.058
-
High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer. Cancer Treat Rep. 1987 Oct; 71(10):915-9.
Score: 0.056
-
High-dose intensity systemic therapy of metastatic bladder cancer. J Clin Oncol. 1987 Mar; 5(3):450-5.
Score: 0.054
-
Chemotherapy-induced vomiting: circadian drug timing as a source of predictable within-patient variability. Cancer Treat Rep. 1986 Nov; 70(11):1347-8.
Score: 0.053
-
Advanced transitional cell bladder cancer: a treatable disease. Semin Surg Oncol. 1986; 2(2):76-89.
Score: 0.050
-
Cisplatin chronotherapy and disulfiram rescue reduce toxicity without interfering with anticancer activity: animal findings and preliminary clinical experiences. Chronobiol Int. 1986; 3(1):55-64.
Score: 0.050
-
Lack of antiemetic effect of high-dose metoclopramide. J Clin Oncol. 1985 Sep; 3(9):1273-6.
Score: 0.049
-
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol. 2005 Sep; 16(9):1449-57.
Score: 0.048
-
Chemotherapy via implanted infusion pump: new perspectives for delivery of long-term continuous treatment. Oncol Nurs Forum. 1986 Mar-Apr; 13(2):17-24.
Score: 0.013
-
Circadian mesor of recumbent pulse--cost-effective predictor of doxorubicin-induced congestive heart failure. Chronobiol Int. 1984; 1(1):59-66.
Score: 0.011
-
The clinical application of chronobiology to oncology. Am J Anat. 1983 Dec; 168(4):519-42.
Score: 0.011
-
Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats. Oncology. 1985; 42(1):48-54.
Score: 0.003